June 10th, 2023

Eisai and Biogen's (Nasdaq: BIIB) Alzheimer's drug candidate, LEQEMBI (lecanemab-irmb), received unanimous support from FDA PCNS panel based on Phase 3 Clarity AD trial data.  The committee acknowledged its clinical benefit, overall benefit-r. Read more

June 10th, 2023

General Electric Company's (NYSE: GE) subsidiary, GE Aerospace, has secured a significant contract from the Defense Logistics Agency Aviation for supplies related to the F-series engines (F101/110/118).  The firm-fixed price, requirements-typ. Read more

June 09th, 2023

23andMe Holding Co. (Nasdaq: ME), a leading genetic testing and personal genomics company, has disclosed in a regulatory filing with the SEC a reduction in force involving around 75 employees, representing approximately 9% of its workforce.  . Read more

June 09th, 2023

Theravance Biopharma Ireland Limited, an affiliate of Theravance Biopharma, Inc. (Nasdaq: TBPH), entered into a global license agreement with Pfizer Inc. (NYSE: PFE) in December 2019 for its preclinical skin-selective, locally acting pan-JAK inhibito. Read more

June 09th, 2023

Aehr Test Systems (Nasdaq: AEHR) has secured significant orders worth $13.7 million from a leading Fortune 500 semiconductor device supplier, who is a major player in the automotive semiconductor market.  The orders are for Aehr's WaferPak fu. Read more

June 09th, 2023

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics AG (Nasdaq: CRSP) have announced positive results from pivotal trials for their investigational treatment, exagamglogene autotemcel (exa-cel), in patients with transfusion-dep. Read more

June 09th, 2023

Joby Aviation, Inc. (NYSE: JOBY), a leading electric aviation company focused on the development of vertical takeoff and landing (VTOL) aircraft, has been initiated with a Buy rating and Price Target of $8 by Canaccord Genuity.  With $JOBY cl. Read more

June 09th, 2023

Braze, Inc. (Nasdaq: BRZE) reported a first-quarter fiscal 2024 loss of $0.13 per share, better than the consensus estimate of a loss of $0.18 per share.  The company has also provided guidance for the second quarter, expecting an adjusted lo. Read more

June 09th, 2023

Oculis Holding AG (Nasdaq: OCS), a leading pharmaceutical company specializing in developing innovative therapies for ocular diseases, has been initiated with an Outperform rating and a price target of $58 by Robert W. Baird. With $OCS closing at . Read more

June 08th, 2023

Raytheon Intelligence & Space, a key business segment of Raytheon Technologies Corp. (NYSE: RTX), has been awarded a significant contract worth $372,137,000 by the Naval Air Warfare Center Weapons Division.  The contract entails updates, impr. Read more